Patents by Inventor Morgan KARLSSON

Morgan KARLSSON has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10077321
    Abstract: A method for manufacturing a shaped cross-linked hyaluronic acid product, the method including the step of subjecting a non-cross-linked precipitated hyaluronic acid substrate in a desired shape to a single cross-linking reaction in a liquid medium having a pH of 11.5 or higher and including one or more polyfunctional cross-linking agent(s) and an amount of one or more organic solvent(s) giving precipitating conditions for hyaluronic acid, under suitable conditions to obtain a precipitated, shaped cross-linked hyaluronic acid product having a degree of modification of 1-40 cross-linking agent units per 1000 disaccharide units.
    Type: Grant
    Filed: June 28, 2013
    Date of Patent: September 18, 2018
    Assignee: GALDERMA S.A.
    Inventors: Morgan Karlsson, Anne Helander Kenne, Åke Öhrlund
  • Patent number: 10077320
    Abstract: Efficient cross-linking of hyaluronic acid (HA) is provided by a manufacturing process. In the process, HA is activated by an initial cross-linking in an aqueous solution. Unreacted cross-linking agent is removed from the activated HA. Cross-linking of the activated HA is finalized, without addition of any additional cross-linking agent, in a suspension of a liquid precipitating medium and the activated HA in precipitated form. The resulting cross-linked HA products exhibit high effective cross-linker ratio and other favorable properties, making the products useful as implants and in medical and cosmetic surgery.
    Type: Grant
    Filed: June 5, 2014
    Date of Patent: September 18, 2018
    Assignee: GALDERMA S.A.
    Inventors: Morgan Karlsson, Katarina Edsman
  • Publication number: 20180223053
    Abstract: A process for manufacturing a cross-linked hyaluronic acid (HA) gel product is comprising the steps of: (a) preparing an aqueous mixture of HA and a cross-linking agent selected from multiepoxides and diepoxides; wherein the HA is dissolved in an aqueous solution containing 1-10% (w/w) inorganic hydroxide; and wherein the dissolved HA constitutes more than 10% (w/w) of the final mixture; and (b) subjecting the aqueous mixture to cross-linking conditions to allow the dissolved HA to react with the cross-linking agent so as to obtain a cross-linked HA gel product.
    Type: Application
    Filed: July 18, 2016
    Publication date: August 9, 2018
    Applicant: GALDERMA SA
    Inventor: Morgan KARLSSON
  • Publication number: 20160376382
    Abstract: Efficient cross-linking of hyaluronic acid (HA) is provided by a manufacturing process. In the process, HA is activated by an initial cross-linking in an aqueous solution. Unreacted cross-linking agent is removed from the activated HA. Cross-linking of the activated HA is finalized, without addition of any additional cross-linking agent, in a suspension of a liquid precipitating medium and the activated HA in precipitated form. The resulting cross-linked HA products exhibit high effective cross-linker ratio and other favorable properties, making the products useful as implants and in medical and cosmetic surgery.
    Type: Application
    Filed: June 5, 2014
    Publication date: December 29, 2016
    Applicant: GALDERMA S.A.
    Inventors: Morgan KARLSSON, Katarina EDSMAN
  • Publication number: 20160145357
    Abstract: A method for manufacturing a shaped cross-linked hyaluronic acid product, the method including the step of subjecting a non-cross-linked precipitated hyaluronic acid substrate in a desired shape to a single cross-linking reaction in a liquid medium having a pH of 11.5 or higher and including one or more polyfunctional cross-linking agent(s) and an amount of one or more organic solvent(s) giving precipitating conditions for hyaluronic acid, under suitable conditions to obtain a precipitated, shaped cross-linked hyaluronic acid product having a degree of modification of 1-40 cross-linking agent units per 1000 disaccharide units.
    Type: Application
    Filed: June 28, 2013
    Publication date: May 26, 2016
    Applicant: GALDERMA S.A.
    Inventors: Morgan KARLSSON, Anne HELANDER KENNE, Åke ÖHRLUND